Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 164.40 SEK | -4.31% |
|
-8.36% | -27.89% |
| 07-17 | Affarsvarlden issues a neutral recommendation for Raysearch after the profit warning | FW |
| 07-16 | RaySearch Laboratories AB Provides Earnings Guidance for the Second Quarter of 2026 | CI |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 5,636 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -27.89% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 5,793 | 5,629 | 5,402 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -25.77% | -2.83% | -4.03% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 19.9x | 16.2x | 13.4x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 6.23x | 5.06x | 4.13x |
| PEG | - | -1x | 0x | 0x | 2.9x | 0.8x | 0.7x | 0.6x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 3.99x | 3.42x | 3.03x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.1x | 3.42x | 2.9x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 8.86x | 7.44x | 6.17x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 16.4x | 12.6x | 9.71x |
| EV / FCF | 234x | - | - | - | 21.7x | 29.7x | 18.6x | 13.6x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 3.37% | 5.38% | 7.37% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 5.07 | 6.15 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.43% | 3.08% | 3.74% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 8.27 | 10.14 | 12.3 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 48.4% | 50% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,412 | 1,648 | 1,862 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 653.5 | 756.5 | 876 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 353 | 448.5 | 556.5 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 280 | 341 | 413 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 157 | -7 | -234 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 164.40 | 164.40 | 164.40 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | - | - |
| Announcement Date | 2/23/22 | 2/28/23 | 2/23/24 | 2/21/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.77x | 4.28x | 9.25x | 2.33% | 608M | |
| 28.85x | 6.25x | 13.83x | -.--% | 29.98B | |
| 79.94x | 68.43x | 85.24x | 0.46% | 12.68B | |
| 79.92x | 11.78x | 51.13x | 0.73% | 5.41B | |
| -30.41x | 8.51x | -46.08x | - | 2.09B | |
| 52.38x | - | - | -.--% | 1.86B | |
| -6.08x | 60.28x | -6.11x | - | 1.78B | |
| -112.53x | - | - | - | 1.05B | |
| 5.92x | - | - | - | 855M | |
| 108.67x | - | - | 1.23% | 746M | |
| Average | 22.74x | 26.59x | 17.88x | 0.79% | 5.71B | |
| Weighted average by Cap. | 40.55x | 23.72x | 31.79x | 0.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
